Searchable abstracts of presentations at key conferences in endocrinology

ea0016p52 | Adrenal | ECE2008

Relation between serum adiponectin level, subclinical Cushing's syndrome and non-functional adrenal incidentaloma

Unal Asli Dogruk , Ayturk Semra , Kemal Yasemin , Tutuncu Neslihan Bascil , Demirag Nilgun Guvener

In this study we compared plasma adiponectin levels between patients with non-functional adrenal incidentaloma and subclinical Cushing’s syndrome. Our aims were to determine whether there was any difference of plasma adiponectin levels, any relation between cardiovasculer risk factors and to investigate the importance of adiponectin levels in subclinical Cushing’s syndrome patients according to non-functional adrenal incidentaloma patients. The patients referred from...

ea0016p392 | Neuroendocrinology | ECE2008

Macroprolactinemia seems to have a positive effect on platelet activation through ADP stimulation

Anaforoglu Inan , Ertorer Eda , Kozanoglu Ilknur , Unal Birsel , Haydardedeoglu Filiz , Tutuncu Neslihan Bascil , Demirag Nilgun Guvener

Objective: Platelet activation is a recently recognized characteristic of prolactin, which functions through the potentiation of ADP-induced P-selectin expression on platelets. Studies in hyperprolactinemic patients demonstrated atherosclerotic disorders related to insulin resistance; convenient milieus for platelet activation. To investigate the association between hyperprolactinemia and platelet activation related to P-selectin expression, we studied on hyperprolactinemic an...

ea0014p34 | (1) | ECE2007

Ambulatory blood pressure reduction after rosiglitazone treatment in normotensive type 2 diabetic patients

Kemal Yasemin , Tutuncu Neslihan , Guvener Nilgun , Unal Asli , Atar Ilyas , Muderrisoglu Haldun

Objective: The thiazolidinediones are new and potentially useful developments in the treatment of type 2 diabetes and impaired glucose tolerance. We tested the effects of the thiazolidinedione, rosiglitazone on blood pressure in normotensive type 2 diabetes.Methods: After receiving approval from the local ethics committee, 25 normotensive diabetic patients were were enrolled to the study. Before the rosiglitazone treatment we measured plasma glucose, HbA...

ea0014p35 | (1) | ECE2007

Time dependent effects of rosiglitazone on heart and fluid dynamics: a 6-month follow up study

Kemal Yasemin , Demirag Nilgun , Tutuncu Neslihan , Yildirir Aylin , Atar Asli , Unal Asli

Objective: Thiazolidinediones (TZDs) have become a powerful tool for lowering insulin resistance. The problem of cardiovascular adverse events including fluid retention and risk of heart failure, although of a low incidence, should be well known and recognized. We aimed to evaluate the effects of rosiglitazone treatment on cardiac function and show whether these effects are reversible when we continued this treatment.Methods: Fourty-six type 2 diabetic p...

ea0049ep56 | Adrenal cortex (to include Cushing's) | ECE2017

The frequency of incidental liver and renal masses in patients with adrenal incidentalomas

Nasiroglu Imga Narin , Tutuncu Yasemin , Unal Mustafa , Tuna Mazhar Muslum , Aycicek Bercem , Isik Serhat , Berker Dilek , Guler Serdar

Purpose: Adrenal incidentalomas (AIs) are adrenal masses, which are found on imaging studies not performed related to an adrenal problem. Hepatic incidental masses and renal incidental masses are usually seen in abdominal imaging methods. We aim to investigate the frequency and the kind of hepatic and renal incidental masses in patients with AIs.Methods: Retrospective evaluation of 381 (245 female and 136 male) AI patients and 285 (168 female and 117 mal...

ea0041gp182 | Reproduction & Endocrine Disruption | ECE2016

Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome

Calan Mehmet , Yilmaz Ozgur , Kume Tuncay , Unal Kocabas Gokcen , Yesil Senses Pinar , Mehmet Senses Yasar , Temur Muzaffer , Gursoy Calan Ozlem

Context: Betatrophin is a newly identified hormone appreciated for its role as a potent inducer of beta cell proliferation in line with insulin resistance in mice. Polycystic ovary syndrome (PCOS) is an inflammatory-based metabolic disease associated with insulin resistance. However, no evidence was available whether betatrophin is involved in women with PCOS.Objective: To ascertain whether betatrophin levels are altered in women with PCOS.<p class="...

ea0041ep990 | Thyroid (non-cancer) | ECE2016

The value of blood cell markers in patients with thyroid nodules including atypia of undetermined significance/follicular lesion of undetermined significance cytology

Arpaci Dilek , Cakmak Guldeniz Karadeniz , Emre Ali Ugur , Unal Mustafa , Kuzu Fatih , Bahadir Burak , Bilici Muammer , Bayraktaroglu Taner

Background: Atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) is a heterogeneous that cannot be definitively diagnosed as benign, malignancy-suspect, or malignant. The estimated risk of AUS/FLUS malignancy is reported 5% to 15% according to the Bethesda System (BS). This study was conducted to evaluate the ability of mean platelet volume (MPV) and neutrophil-to-lymphocyte ratio (NLR) to predict the malignant potential of nodules diag...

ea0037ep219 | Reproduction, endocrine disruptors and signalling | ECE2015

The relationships of bisphenol A levels with leptin and adiponectin in premenopausal women

Polat Sevgi , Yurekli Banu Sarer , Kocabas Gokcen Unal , Durusoy Raika , Aksit Murat , Bozkaya Giray , Yuksel Arif , Saygili Fusun

Aim: Bisphenol A (BPA) is the most common endocrine disruptor among environmental estrogens. BPA is an ingredient that is commonly used in polycarbonate plastics. In this study, our main concern is to measure the levels of BPA in premenopausal obese women and to examine the relationship of BPA with adiponectin and leptin.Materials and methods: 47 obese women and 39 non-obese healthy women were enrolled in this study. All participants were premenopausal. ...

ea0037ep621 | Obesity and cardiovascular endocrinology | ECE2015

Metabolic syndrome and muscle mass

Ergen Nilay , Unal Asli Dogruk , Cigerli Ozlem , Parildar Hulya , Tarcin Ozlem , Altun Betul Ugur , Demirag Nilgun Guvener

Objective: Low skeletal muscle mass is an emerging risk factor for metabolic disorders. In this study, we aimed to evaluate the relationships between fat mass, muscle mass, muscle fat mass ratio, total fat mass, and abdominal fat mass ratio by comparing the body compositions in obese women with and without metabolic syndrome.Methods: Totally 89 obese women (mean±S.D., age 42.1±12 years, BMI 36.5±4.2%) with newly diagnosed me...

ea0037ep1284 | Clinical Cases–Thyroid/Other | ECE2015

Two cases of bullous pemphigoid induced by vildagliptin

Unal Asli Dogruk , Tarcin Ozlem , Demirci Gulsen Tukenmez , Demiralay Ebru , Mansur Ayse Tulin , Yildiz Semsi , Demirag Nilgun Guvener

Background: Bullous pemphigoid is an autoimmune blistering disease that commonly arise in elderly with increased risk for mortality and morbidity. The aetiology of this disease is not entirely clear, although a few cases have been described with dipeptidyl peptidase IV inhibitors.Case 1: A 81-year-old man presented with bullous pemphigoid after 28-month treatment with repaglinide, vildagliptin, and metformin. The patient’s condition didn’t impr...